IRIS
MILANESE, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.362
AS - Asia 3.433
NA - Nord America 2.878
Continente sconosciuto - Info sul continente non disponibili 642
SA - Sud America 277
AF - Africa 53
OC - Oceania 7
Totale 27.652
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 19.834
US - Stati Uniti d'America 2.669
SG - Singapore 1.341
CN - Cina 881
VN - Vietnam 585
BD - Bangladesh 323
FR - Francia 187
BR - Brasile 163
HK - Hong Kong 104
FI - Finlandia 88
CA - Canada 80
MX - Messico 58
GB - Regno Unito 52
AR - Argentina 51
DE - Germania 41
JP - Giappone 39
ID - Indonesia 27
ES - Italia 20
IQ - Iraq 20
JM - Giamaica 19
PL - Polonia 19
CO - Colombia 17
ZA - Sudafrica 17
CH - Svizzera 16
IN - India 16
UA - Ucraina 14
NL - Olanda 13
PH - Filippine 13
RU - Federazione Russa 13
EC - Ecuador 12
SA - Arabia Saudita 11
IE - Irlanda 10
TT - Trinidad e Tobago 10
TW - Taiwan 10
AE - Emirati Arabi Uniti 9
HN - Honduras 9
VE - Venezuela 9
CL - Cile 8
PY - Paraguay 8
TR - Turchia 8
CR - Costa Rica 7
DZ - Algeria 7
PK - Pakistan 7
SE - Svezia 7
AT - Austria 6
AU - Australia 6
MY - Malesia 6
BO - Bolivia 5
JO - Giordania 5
LT - Lituania 5
MA - Marocco 5
RO - Romania 5
SI - Slovenia 5
SV - El Salvador 5
GT - Guatemala 4
KE - Kenya 4
KR - Corea 4
NI - Nicaragua 4
TH - Thailandia 4
TN - Tunisia 4
BS - Bahamas 3
GR - Grecia 3
MD - Moldavia 3
PT - Portogallo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
BB - Barbados 2
BE - Belgio 2
EE - Estonia 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
KZ - Kazakistan 2
MK - Macedonia 2
MT - Malta 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
XK - ???statistics.table.value.countryCode.XK??? 2
AI - Anguilla 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
Totale 27.001
Salva come PNG Salva come JPEG
Città #
Genova 9.343
Genoa 6.838
Vado Ligure 1.683
Rapallo 1.492
San Jose 727
Singapore 692
Ashburn 270
Ho Chi Minh City 188
Lauterbourg 155
Beijing 137
Hanoi 130
New York 118
Council Bluffs 99
Hong Kong 98
Helsinki 83
Los Angeles 69
Rome 56
Santa Clara 56
Milan 45
Bordighera 40
Tokyo 33
Buffalo 32
Da Nang 31
Frankfurt am Main 30
Orem 30
Haiphong 29
São Paulo 29
Atlanta 28
Chicago 27
Mexico City 27
Turin 27
Montreal 22
Phoenix 20
Dallas 18
Tianjin 17
Naples 16
Toronto 16
Zurich 16
Basingstoke 15
Houston 15
The Dalles 15
Kyiv 13
Baghdad 12
Boardman 12
Biên Hòa 11
Brooklyn 11
Florence 11
Hải Dương 11
Kingston 11
Piscataway 11
St Louis 11
Bologna 10
Charlotte 10
Dublin 10
Johannesburg 10
Las Vegas 10
Miami 10
Warsaw 10
Amsterdam 9
Denver 9
London 9
Osio Sopra 9
Phủ Lý 9
Winnipeg 9
Can Tho 8
Fort Myers 8
Louisville 8
Staten Island 8
Cleveland 7
Hamden 7
Jakarta 7
Lexington 7
Memphis 7
Messina 7
Paris 7
Philadelphia 7
Quảng Ngãi 7
San Francisco 7
Tampa 7
Virginia Beach 7
Barcelona 6
Buenos Aires 6
Catania 6
Denton 6
Detroit 6
Jacksonville 6
Madrid 6
Newark 6
North Bergen 6
Padua 6
Pasadena 6
Quito 6
Salt Lake City 6
Thái Bình 6
Amman 5
Bari 5
Bắc Ninh 5
Carrollton 5
Cincinnati 5
Guayaquil 5
Totale 23.280
Salva come PNG Salva come JPEG
Nome #
Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis 243
Acute stress increases depolarization-evoked glutamate release and presynaptic SNARE complex accumulation in prefrontal/frontal cortex. The dampening action of antidepressants. 240
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis. 239
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 235
Altered intracellular calcium homeostasis underlying enhanced glutamatergic transmission in striatal-enriched tyrosine phosphatase (STEP) knockout mice 233
CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice 221
Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease 211
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways 210
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosis at a Pre-Symptomatic Stage of the Disease. 210
Chronic mild stress induces anhedonic behavior and changes in glutamate release, BDNF trafficking and dendrite morphology only in stress vulnerable rats. The rapid restorative action of ketamine 205
Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS 200
Prophylactic versus therapeutic fingolimod: Restoration of presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis 196
Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis. 194
The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release 187
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 187
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis 185
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 180
Colocalization of neurotransmitter transporters on the plasma membrane of the same nerve terminal may reflect cotransmission. 180
Sox2 conditional mutation in mouse causes ataxic symptoms, cerebellar vermis hypoplasia, and postnatal defects of Bergmann glia 179
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone 177
The high-mobility group box 1 cytokine induces transporter-mediated release of glutamate from glial subcellular particles (gliosomes) prepared from in situ-matured astrocytes 176
Enriched experience and recovery from amblyopia in adult rats: impact of motor, social and sensory components. 174
Synthesis and evaluation of resins bearing substrate-like inhibitor functions for capturing copper amine oxidases 172
Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by ‘pathologically’ elevated extraterminal K+ concentrations 171
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 170
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. 170
Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice 170
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 167
Metabotropic glutamate receptor 5 as a potential target in ALS 167
A New Function for Glycine GLYT2 Transporters: Stimulation of GABA Release from Cerebellar Nerve Terminals Through GAT-1 Transporter Reversal and Ca2+-Dependent Anion Channels 166
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex 164
The complex phenotype and function of spinal cord microglia during ALS progression and the impact of metabotropic glutamate receptor type 5 down-regulation in SOD1G93A mice 162
Excessive and precocious glutamate release in the spinal cord of a mouse model of amyotrophic lateral sclerosis 162
Functional expression of release-regulating glycine transporters GLYT1 on GABAergic neurons and GLYT2 on astrocytes in mouse spinal cord 161
Amyotrophic lateral sclerosis and excitotoxicity: role of Group I metabotropic glutamate receptors 161
The P2X7 receptor as a route for non-exocytotic glutamate release: dependence on the carboxyl tail 161
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes 160
Abnormal and precocious exocytotic glutamate release in a mouse model of amyotrophic lateral sclerosis 160
Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis 160
Differential expression of metabotropic glutamate and GABA receptors at neocortical glutamatergic and GABAergic axon terminals 158
Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain 158
Glutamate release from astrocytic gliosomes under physiological and pathological conditions 157
Adult astroglia is competent for Na+/Ca2+ exchanger-operated exocytotic glutamate release triggered by mild depolarization 156
Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down Syndrome. 155
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosisat a Pre-Symptomatic Stage of the Disease. 155
DIABETIC NEUROPATHIC PAIN: A ROLE FOR TESTOSTERONE METABOLITES 154
Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein 154
Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis 154
CCL5-glutamate crosstalk and presynaptic defects in EAE mice 153
Role of calpain-1 in the early phase of experimental ALS 149
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 148
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 148
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 147
mGluR1 and mGluR5 knock-down improves survival, motor skills and disease progression in amyotrophic lateral sclerosis mouse model 147
Astrocyte contribution to the excessive glutamate release in the spinal cord of the SOD1G93A mouse model of amyotrophic lateral sclerosis 147
Abnormal glutamate release induced by group I metabotropic glutamate receptors in experimental ALS. 147
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 146
Targeting Group I Metabotropic Glutamate Receptors in Amyotrophic Lateral Sclerosis 146
Acute stress and corticosterone increase the readily releasable pool of glutamatergic vesicles in rat synaptosomes of prefrontal/frontal cortex via mineralocorticoid and glucocorticoid receptors 146
In vitro Evidence of Abnormal Glutamate to Glutamine Conversion in Astrocytes harvested from a Mouse Model of Amyotrophic Lateral Sclerosis: a potential Experimental Application of N-13-ammonia 146
TPP-Based Nanovesicles Kill MDR Neuroblastoma Cells and Induce Moderate ROS Increase, While Exerting Low Toxicity Towards Primary Cell Cultures: An In Vitro Study 144
Group I metabotropic glutamate receptors tune excitotoxicity in amyotrophic lateral sclerosis 143
Genetic and pharmacological effects of mGlu5 receptor blockade in the SOD1G93A mouse model of amyotrophic lateral sclerosis 143
Unusual increase in lumbar network excitability of the rat spinal cord evoked by the PARP-1 inhibitor PJ-34 through inhibition of glutamate uptake. 142
Neurounina-1, a Novel Compound that Increases Na+/Ca2+ Exchanger Activity, Effectively Protects Against Stroke Damage 142
Acute ketamine restores deficits in glutamate release and related molecular mechanisms induced by chronic mild stress in vulnerable rats 142
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice 141
Agomelatine reduces glutamate release induced by acute stress, possible synergism between melatonin and 5HT2C properties 140
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone. 140
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 140
A multistationary loop model of ALS unveils critical molecular interactions involving mitochondria and glucose metabolism 139
The GABAergic-like system in the cyprid of Balanus amphitrite (=Amphibalanus amphitrite) (Cirripedia, Crustacea) 138
Environmental therapy for cognitive and sensory impairment in a mouse model of Down syndrome 138
Release of [3H]D-aspartate induced by K+-stimulation is increased in the cervical spinal cord of wobbler mice, a model of motor neuron disease. 137
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cells 137
GroupI metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 136
GROUP I METABOTROPIC GLUTAMATE RECEPTORS AND NEUROTOXICITY IN AMYOTROPHIC LATERAL SCLEROSIS 136
Alterations of Synaptic Mechanisms and Excessive Glutamate Release in the Spinal Cord of SOD1G93A Mice 136
Altered synaptic mechanisms and excessive glutamate release in amyotrophic lateral sclerosis 135
Alterations of Synaptic Mechanisms and Excessive Glutamate Release in the Spinal Cord of SOD1G93A Mice 135
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings 133
Synaptic mechanisms underlying the excessive and precocious glutamate release in the spinal cord of sod1g93a mice. 133
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 133
Knocking-down mGluR1 and mGluR5 in the SOD1/G93A mouse model of amyotrophic lateral sclerosis ameliorates survival and disease progression 133
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis 133
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell 132
Cognitive impairment in Gdi1 deficient mice is associated with altered synaptic vesicle pools and short-term synaptic plasticity, and can be corrected by appropriate learning training 132
Group I metabotropic glutamate receptors in ALS: knocking-down mGlu1 receptors ameliorates survival and disease progression in SOD1/G93A mice. 131
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice 131
The Role of Endoplasmic Reticulum in the Differential Endurance against Redox Stress in Cortical and Spinal Astrocytes from the Newborn SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis 131
Molecular mechanisms supporting abnormal glutamate release in the spinal cord of a mouse model of Amyotrophic Lateral Sclerosis. 130
Targeting group i metabotropic glutamate receptors in experimental als. 130
Gamma-amino butyric acid (GABA) release in the ciliated protozoon Paramecium occurs by neuronal-like exocytosis 129
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosis 129
Group I metabotropic glutamate receptors modulate glutamate exocytosis in a mouse model of als 128
The Modulation of Glutamate Release by Group I Metabotropic Glutamate Auto-Receptors in ALS 127
Knocking-down mGlu1 receptors prolongs survival and ameliorates disease progression in the SOD1/G93A mouse model of ALS. 127
Genetic and pharmacological effects by blocking mGlu5 Receptor in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis 127
Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex 127
Increased [3H]D-aspartate release and changes in glutamate receptor expression in the hippocampus of the mnd mouse. 126
Totale 15.823
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.732
article - articoli 41.428
book - libri 1.127
conference - conferenze 44.177
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.464
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.900 37 119 108 191 79 148 123 470 107 173 69 276
2022/20231.838 187 169 23 206 274 289 12 116 295 14 212 41
2023/20241.510 50 175 49 178 124 302 119 67 65 70 108 203
2024/20254.530 218 307 124 307 501 425 384 803 131 200 522 608
2025/20269.074 1.033 242 547 662 1.352 614 1.270 500 732 889 540 693
2026/2027863 863 0 0 0 0 0 0 0 0 0 0 0
Totale 27.652